Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Functional Magnetic Resonance Imaging of Patients Receiving Intravenous Ketamine for Treatment Resistant Bipolar Depression

NCT06620042 is registered in ClinicalTrials.gov with Brian Barnett as lead sponsor.

NCT NCT06620042
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06620042 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Functional Magnetic Resonance Imaging of Patients Receiving Intravenous Ketamine for Treatment Resistant Bipolar Depression
Lead sponsor
Brian Barnett
Phase
Phase 2
Overall status
Completed
Start date
November 12, 2024
Completion date
October 31, 2025
Enrollment
20 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

bipolar depression, treatment resistant bipolar depression